ILinagliptin yoMzali iNyucleus ePhakathi CAS 853029-57-9 Ubunyulu ≥99.0% Factory

Inkcazelo emfutshane:

Igama: I-Linagliptin yoMzali iNyucleus ePhakathi

CAS: 853029-57-9

Ubunyulu: ≥99.0%

Imbonakalo: Umgubo oMhlophe ukuya kokuKhanyayo oMthubi

I-Intermediate ye-Linagliptin (CAS: 668270-12-0) yonyango lwe-II diabetes mellitus

Umgangatho ophezulu, iMveliso yoRhwebo

E-Mail: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo loMvelisi iLinagliptin kunye neMidiya eNxulumeneyo:
I-Linagliptin CAS 668270-12-0
ILinagliptin yoMzali iNyucleus ePhakathi CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
I-8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
I-2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0

Iipropati zeMichiza:

Igama leMchiza	I-8-Bromo-7-kodwa-2-ynyl-3-methyl-1- (4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
Izithethantonye	I-Nyucleus yoMzali iLinagliptin;ILinagliptin ePhakathi F
Inombolo yeCAS	853029-57-9
Inombolo yeCAT	RF-PI502
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	I-C20H17BrN6O2
Ubunzima beMolekyuli	453.29
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMhlophe ukuya koMthubi oKhanyayo
Ukuchongwa	IR/HPLC
Ubunyulu	≥99.0%
Amanzi (KF)	≤1.0%
Intsalela kwi-Ignition	≤0.50%
Ukungcola ngokupheleleyo	≤1.0%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	Esiphakathi kwiLinagliptin (CAS: 668270-12-0)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi.

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma.

Izinto eziluncedo:

FAQ:

Isicelo:

I-8-Bromo-7-kodwa-2-ynyl-3-methyl-1- (4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione (CAS: 853029-57- 9) yinucleus yomzali weLinagliptin (CAS: 668270-12-0).I-Linagliptin (amagama orhwebo i-Tradjenta kunye ne-Trajetna) sisithinteli se-dipeptidyl peptidase-4 (DPP-4) eyavunywa yi-US FDA ngoMeyi ka-2011 kunyango lwe-Type 2 yeswekile kunye nokutya kunye nokuzilolonga.I-Linagliptin (BI-1356) ichazwe njengeyona nto inamandla yokukhetha, isantya esicothayo kunye ne-inhibitor esebenza ixesha elide ye-DPP-4.I-Linagliptin ivele kwimizamo yokuphucula i-xanthine-based DPP-4 inhibitors kunye nesikhokelo sokuqala esichongiweyo kwiphulo le-HTS.